MN

Active Director Director DIN 10198349
DIN 10198349 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Md Nishat

Data last updated:

Md Nishat is a Director at Morp Mediz Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Morp Mediz Pharmaceuticals Private Limited reported revenue of ₹2.9 Lakh (FY 2025).

DIN 10198349
Primary Designation Director
Industry Pharma
First Appointment 12 Jun 2023
Oldest Company Age 3 yrs
Largest company Morp Mediz Pharmaceuticals Private Limited · ₹2.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jun 20232023₹2.9 Lakh (FY 2025)Active

Board colleagues of Md Nishat

NameDINCompanyDesignation
Mojahid10198350Morp Mediz Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Morp Mediz Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Md Nishat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Md Nishat

Md Nishat currently holds 1 directorship: Morp Mediz Pharmaceuticals Private Limited (Director, since 12 Jun 2023, revenue ₹2.9 Lakh (FY 2025)).

Md Nishat was first appointed on 12 Jun 2023 as Director at Morp Mediz Pharmaceuticals Private Limited.

The current boards of Md Nishat's companies include Mojahid (Morp Mediz Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available